↓ Skip to main content

Dove Medical Press

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

Overview of attention for article published in OncoTargets and therapy, December 2010
Altmetric Badge

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
84 Mendeley
Title
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
Published in
OncoTargets and therapy, December 2010
DOI 10.2147/ott.s10155
Pubmed ID
Authors

Carmen Criscitiello, Debora Fumagalli, Kamal S Saini, Sherene Loi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Australia 1 1%
Unknown 82 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 18%
Student > Bachelor 10 12%
Student > Master 8 10%
Other 7 8%
Researcher 7 8%
Other 20 24%
Unknown 17 20%
Readers by discipline Count As %
Medicine and Dentistry 17 20%
Biochemistry, Genetics and Molecular Biology 16 19%
Agricultural and Biological Sciences 11 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Unspecified 4 5%
Other 13 15%
Unknown 19 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2020.
All research outputs
#8,713,411
of 25,806,080 outputs
Outputs from OncoTargets and therapy
#564
of 3,016 outputs
Outputs of similar age
#58,476
of 193,027 outputs
Outputs of similar age from OncoTargets and therapy
#1
of 2 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,027 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them